Federal (United States) · Session law
Title XI
15 sections
15 sections
- Pub. L. 108-173, tit. XI, subtit. A, sec. 1101THIRTY-MONTH STAY-OF-EFFECTIVENESS PERIOD.Enacted
- Pub. L. 108-173, tit. XI, subtit. A, sec. 1102FORFEITURE OF 180-DAY EXCLUSIVITY PERIOD.Enacted
- Pub. L. 108-173, tit. XI, subtit. A, sec. 1103BIOAVAILABILITY AND BIOEQUIVALENCE.Enacted
- Pub. L. 108-173, tit. XI, subtit. A, sec. 1104CONFORMING AMENDMENTS.Enacted
- Pub. L. 108-173, tit. XI, subtit. B, sec. 1111DEFINITIONS.Enacted
- Pub. L. 108-173, tit. XI, subtit. B, sec. 1112NOTIFICATION OF AGREEMENTS.Enacted
- Pub. L. 108-173, tit. XI, subtit. B, sec. 1113FILING DEADLINES.Enacted
- Pub. L. 108-173, tit. XI, subtit. B, sec. 1114DISCLOSURE EXEMPTION.Enacted
- Pub. L. 108-173, tit. XI, subtit. B, sec. 1115ENFORCEMENT.Enacted
- Pub. L. 108-173, tit. XI, subtit. B, sec. 1116RULEMAKING.Enacted
- Pub. L. 108-173, tit. XI, subtit. B, sec. 1117SAVINGS CLAUSE.Enacted
- Pub. L. 108-173, tit. XI, subtit. B, sec. 1118EFFECTIVE DATE.Enacted
- Pub. L. 108-173, tit. XI, subtit. C, sec. 1121IMPORTATION OF PRESCRIPTION DRUGS.Enacted
- Pub. L. 108-173, tit. XI, subtit. C, sec. 1122STUDY AND REPORT ON IMPORTATION OF DRUGS.Enacted
- Pub. L. 108-173, tit. XI, subtit. C, sec. 1123STUDY AND REPORT ON TRADE IN PHARMACEUTICALS.Enacted